Azora Therapeutics, Inc. (DE)
Public company- Headquarters
- ENCINO, California
- Ticker
- ADIL
- CIK
- 0001513525
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
8
4 appointments, 4 departures
Last event
Oct 28, 2026
Executive appointmentCEO appointed: Matthew Davidson, Ph.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOMatthew Davidson, Ph.D. | Oct 28, 2026 | Appointed |
| CFOCelia Economides | Oct 28, 2026 | Appointed |
| Chief Strategy OfficerJulie Saiki, Ph.D. | Oct 28, 2026 | Appointed |
| President and Chief Executive OfficeMatthew Davidson | Aug 13, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
No events of this type on record.
Show all eventsLast verified Nov 8, 2026